Company
| Legal Name | Valneva SE |
| Headquarters | Wien, Austria |
| Website | https://valneva.com |
We are a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. We take a highly specialized and targeted approach, applying our deep expertise across multiple vaccine modalities, focused on providing either first-, best- or only-in-class vaccine solutions. We have a strong track record, having advanced multiple vaccines from early R&D to approvals, and currently market three proprietary travel vaccines, including the world’s first and only chikungunya vaccine, as well as certain third-party vaccines. Revenues from our growing commercial business help fuel the continued advancement of our vaccine pipeline. This includes the only Lyme disease vaccine candidate in advanced clinical development, which is partnered with Pfizer, as well as vaccine candidates against the Zika virus and other global public health threats.
| Country | City | Job Ads |
|---|---|---|
| Austria | Wien | 384 |
| United Kingdom | Livingston | 182 |
| Austria | Vienna | 55 |
| France | Lyon | 48 |
| Sweden | Solna | 38 |
| Austria | Innere | 27 |
| France | Nantes | 23 |
| France | Saint-Herblain | 8 |
| France | Paris | 8 |
| Sweden | Stockholm | 5 |
Loading map...
Legal Form: SE
Company Type: Entreprise cotée en bourse
Company Size: 501 - 1000
Revenue: 25 - 100 million (USD)
Job Ads found: 788
Job Ads per Month: 17.1
Hiring Locations: 12
| Date of first job ad | 02.11.2019, 01:01 |
| Date of last job ad | 19.03.2026, 14:18 |
| Date merged | 22.03.2026, 20:35 |
| Date created | 02.11.2019, 01:01 |